HTLV-1 proviral load after two months' treatment with anti-CCR4 monoclonal antibody mogamulizumab predicts a molecular response to disease and durable clinical remission in leukaemic subtypes of adult T-cell leukaemia/lymphoma
OA Location
Author(s)
Cook, Lucy B
Rowan, Aileen G
Demontis, Maria Antonietta
Marks, Sasha
Bangham, Charles RM
Type
Conference Paper
Date Issued
2016-12-02
Date Acceptance
2021-06-01
Citation
Blood, 2016, 128 (22), pp.5356-5356
URI
URL
DOI
ISSN
0006-4971
Publisher
American Society of Hematology
Start Page
5356
End Page
5356
Journal / Book Title
Blood
Volume
128
Issue
22
Copyright Statement
© 2016 by The American Society of Hematology
Identifier
https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000394452703115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Source
58th Annual Meeting and Exposition of the American-Society-of-Hematology
Subjects
Hematology
Life Sciences & Biomedicine
Science & Technology
Publication Status
Published
Start Date
2016-12-03
Finish Date
2016-12-06
Coverage Spatial
San Diego, CA
Date Publish Online
2021-06-15